Terug
Dagbereik
€ 14,20
€ 15,29
52-Weeksbereik
€ 1,01
€ 16,41
Volume
5.067.498
50D / 200D Gem.
€ 11,98
/
€ 4,61
Vorige Slotkoers
€ 14,60
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -35,7 | 0,4 |
| P/B | 13,7 | 2,9 |
| ROE % | -33,3 | 3,8 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 11,60
-19.0%
Low: € 5,00
High: € 20,00
Forward WPA
-€ 0,43
Omzet Sch.
7,5 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
-€ 0,40
-€ 0,40 – -€ 0,40
|
300 M | 2 |
| FY2029 |
-€ 0,77
-€ 0,77 – -€ 0,77
|
35 M | 4 |
| FY2028 |
-€ 0,66
-€ 0,91 – -€ 0,50
|
3,7 M | 6 |
Belangrijkste Punten
Debt/Equity of 0,14 — conservative balance sheet
Negative free cash flow of -95,58M
PEG of 0,23 suggests growth is underpriced
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-33,27%
ROIC-26,47%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,14
Current Ratio10,04
Interest Coverage0,00
Waardering
P/E Ratio
-35,73
P/B Ratio13,69
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -124,55M |
| ROE | -33,27% | ROA | -31,44% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -95,58M |
| ROIC | -26,47% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,14 | Current Ratio | 10,04 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -35,73 | P/B Ratio | 13,69 |
| P/S Ratio | N/A | PEG Ratio | 0,23 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 4,45B | Enterprise Value | 4,42B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -124,55M | -161,65M | -125,04M | -242,81M | -122,76M |
| EPS (Diluted) | -0,44 | -0,69 | -0,83 | -1,99 | -1,03 |
| Gross Profit | -3,11M | 0,0 | -3,73M | -2,64M | -829.000,0 |
| Operating Income | -131,41M | -179,59M | -141,53M | -247,45M | -124,88M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 396,15M | 502,53M | 395,30M | 514,91M | 501,42M |
| Total Liabilities | 70,98M | 79,03M | 78,61M | 103,06M | 44,89M |
| Shareholders' Equity | 325,17M | 423,50M | 316,69M | 411,85M | 456,53M |
| Total Debt | 47,14M | 51,89M | 55,86M | 55,10M | 18,79M |
| Cash & Equivalents | 73,81M | 67,74M | 93,08M | 284,22M | 360,49M |
| Current Assets | 286,24M | 308,79M | 320,68M | 444,50M | 420,02M |
| Current Liabilities | 28,51M | 31,40M | 26,16M | 48,69M | 26,22M |